Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

51.06
Delayed Data
As of Jun 24
 -2.34 / -4.38%
Today’s Change
46.17
Today|||52-Week Range
60.34
-12.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line1.2B1.3B1.2B1.4B
 
 
 
 
 
Depreciation96.4M94.5M148.3M92.3M
 
 
 
 
 
Total Other Cash Flow469.4M289.0M160.1M143.0M
 
 
 
 
 
Funds From Operations1.8B1.6B1.5B1.6B
 
 
 
 
 
Funds From/For Other Operating Expenses26.7M-167.7M34.6M524.3M
 
 
 
 
 
Net Cash Flow - Operating Activities1.8B1.8B1.5B1.1B
 
 
 
 
 
 
InvestingIncrease In Investments0.00-300.9M-223.1M-72.5M
 
 
 
 
Decrease In Investments178.6M887.0K-2.3M0.00
 
 
 
 
Capital Expenditures-151.9M-185.8M-321.1M-161.3M
 
 
 
 
 
Fixed Asset Disposal768.9K438.7K-862.2K0.00
 
 
 
 
Other Investing - Uses0.00-29.0M29.0M0.00
 
 
 
Net Cash Flow Investing8.7M-491.2M-693.2M-241.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-589.3M-744.4M-645.7M-555.3M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-1.8M-2.5M12.3M-2.4B
 
 
 
 
 
Other Sources - Financing-347.6M0.000.00415.7M
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-938.8M-746.8M-633.5M-2.5B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-3.1M-6.2M2.7M-19.7M
 
 
 
 
 
 
Net Change In Cash851.0M564.6M143.5M-1.7B